1.56
price down icon3.11%   -0.05
after-market 시간 외 거래: 1.53 -0.03 -1.92%
loading
전일 마감가:
$1.61
열려 있는:
$1.63
하루 거래량:
319.21K
Relative Volume:
0.78
시가총액:
$47.76M
수익:
$80.97M
순이익/손실:
$-78.31M
주가수익비율:
-0.1407
EPS:
-11.0849
순현금흐름:
$-129.56M
1주 성능:
-9.30%
1개월 성능:
-0.64%
6개월 성능:
+7.96%
1년 성능:
-22.00%
1일 변동 폭
Value
$1.47
$1.63
1주일 범위
Value
$1.47
$1.78
52주 변동 폭
Value
$1.355
$2.89

Fortress Biotech Inc Stock (FBIO) Company Profile

Name
명칭
Fortress Biotech Inc
Name
전화
781-652-4500
Name
주소
1111 KANE CONCOURSE, BAY HARBOR ISLANDS, NY
Name
직원
0
Name
트위터
@fortressbio
Name
다음 수익 날짜
2024-11-12
Name
최신 SEC 제출 서류
Name
FBIO's Discussions on Twitter

FBIO을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
FBIO
Fortress Biotech Inc
1.56 47.76M 80.97M -78.31M -129.56M -11.08
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.82 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
634.23 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
591.87 36.10B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
270.02 35.03B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
272.17 28.24B 3.81B -644.79M -669.77M -6.24

Fortress Biotech Inc Stock (FBIO) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-03-15 재개 ROTH MKM Buy
2022-08-04 개시 Ladenburg Thalmann Buy
2020-10-02 개시 The Benchmark Company Buy
2019-12-18 개시 B. Riley FBR Buy
2018-02-28 개시 B. Riley FBR, Inc. Buy
2017-07-11 개시 Rodman & Renshaw Buy
2017-03-22 개시 JMP Securities Mkt Outperform
2016-10-03 개시 ROTH Capital Buy
모두보기

Fortress Biotech Inc 주식(FBIO)의 최신 뉴스

pulisher
05:50 AM

Fortress Biotech (FBIO) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance

05:50 AM
pulisher
05:00 AM

Fortress Biotech Inc reports results for the quarter ended December 31Earnings Summary - TradingView

05:00 AM
pulisher
04:07 AM

Fortress Biotech Reports 2024 Financial Results and Recent Corporate Highlights - GlobeNewswire

04:07 AM
pulisher
04:05 AM

Fortress Biotech Transforms Portfolio: Dual FDA Wins, $28M Deal, Latest Earnings - Stock Titan

04:05 AM
pulisher
Mar 29, 2025

Fortress Biotech, Inc. (NASDAQ:FBIO) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 29, 2025
pulisher
Mar 28, 2025

Fortress Biotech’s Mixed Earnings Call: Emrosi’s Launch and Challenges - TipRanks

Mar 28, 2025
pulisher
Mar 28, 2025

Breakthrough: CKPT Secures FDA Approval and $416M Merger Deal in Transformative Year - Stock Titan

Mar 28, 2025
pulisher
Mar 28, 2025

MUSTANG BIO, INC. SEC 10-K Report - TradingView

Mar 28, 2025
pulisher
Mar 28, 2025

Journey Medical Reports 2024 Financial Results - TipRanks

Mar 28, 2025
pulisher
Mar 26, 2025

FDA Green Light for Journey Medical's Rosacea Drug Reshapes 2024 Performance - StockTitan

Mar 26, 2025
pulisher
Mar 25, 2025

Fortress Biotech Inc (FBIO) Q4 2024: Everything You Need To Know Ahead Of Earnings - GuruFocus

Mar 25, 2025
pulisher
Mar 22, 2025

Fortress Biotech (NASDAQ:FBIOP) Trading Up 3.9% – Here’s Why - Defense World

Mar 22, 2025
pulisher
Mar 20, 2025

Fortress Biotech (FBIO) Expected to Announce Earnings on Thursday - Defense World

Mar 20, 2025
pulisher
Mar 19, 2025

Journey Medical Corporation to Announce Year End 2024 Financial Results on March 26, 2025 - GlobeNewswire

Mar 19, 2025
pulisher
Mar 19, 2025

Journey Medical Sets Date for 2024 Annual Results: Dermatology Leader's Financial Update - Stock Titan

Mar 19, 2025
pulisher
Mar 19, 2025

Atria Investments Inc Buys 16,841 Shares of Fortress Biotech, Inc. (NASDAQ:FBIO) - Defense World

Mar 19, 2025
pulisher
Mar 17, 2025

Partex And Fortress Biotech Announce Collaboration To Accelerate Biopharma Asset Evaluation - Nasdaq

Mar 17, 2025
pulisher
Mar 17, 2025

Fortress Biotech, Partex Team Up for Asset Identification, Evaluation Using AI -March 17, 2025 at 09:36 am EDT - Marketscreener.com

Mar 17, 2025
pulisher
Mar 17, 2025

Fortress Biotech partners with Partex for AI-driven drug discovery By Investing.com - Investing.com Australia

Mar 17, 2025
pulisher
Mar 17, 2025

Fortress Biotech partners with Partex for AI-driven drug discovery - Investing.com

Mar 17, 2025
pulisher
Mar 17, 2025

Partex NV and Fortress Biotech, Inc. Announce Strategic Collaboration to Leverage AI in Biopharmaceutical Drug Discovery - Nasdaq

Mar 17, 2025
pulisher
Mar 17, 2025

Partex and Fortress Biotech Announce Strategic - GlobeNewswire

Mar 17, 2025
pulisher
Mar 17, 2025

AI Breakthrough: Fortress Biotech's New Partnership Transforms Drug Development Process - StockTitan

Mar 17, 2025
pulisher
Mar 14, 2025

Biotech Alert: Searches spiking for these stocks today - Yahoo Finance

Mar 14, 2025
pulisher
Mar 13, 2025

Equities Analysts Offer Predictions for FBIO Q1 Earnings - Defense World

Mar 13, 2025
pulisher
Mar 12, 2025

Fortress Biotech (NASDAQ:FBIO) Receives “Buy” Rating from Roth Mkm - Defense World

Mar 12, 2025
pulisher
Mar 11, 2025

Benign Growth For Fortress Biotech, Inc. (NASDAQ:FBIO) Underpins Its Share Price - Simply Wall St

Mar 11, 2025
pulisher
Mar 10, 2025

CKPT Merger Alert: Checkpoint Shareholders Seeking Money Should Contact Julie & Holleman Regarding Sale to Sun Pharma - Longview News-Journal

Mar 10, 2025
pulisher
Mar 10, 2025

Lake Street Downgrades Checkpoint Therapeutics to Hold From Buy, $4.10 Price Target - Marketscreener.com

Mar 10, 2025
pulisher
Mar 10, 2025

Checkpoint (CKPT) Shares Skyrocket After A Takeover Agreement - Stocks Telegraph

Mar 10, 2025
pulisher
Mar 10, 2025

Checkpoint Therapeutics Shares Leap Premarket on Takeover by Sun Pharma -March 10, 2025 at 06:24 am EDT - Marketscreener.com

Mar 10, 2025
pulisher
Mar 10, 2025

Sun Pharma Pays 66% Premium in $355M Checkpoint Therapeutics Acquisition - Stock Titan

Mar 10, 2025
pulisher
Mar 10, 2025

Checkpoint Therapeutics to Be Acquired by India's Sun Pharmaceutical -March 10, 2025 at 04:50 am EDT - Marketscreener.com

Mar 10, 2025
pulisher
Mar 10, 2025

Sun Pharma to acquire Nasdaq-listed Checkpoint Therapeutics for $355 million; shares edge higher - Mint

Mar 10, 2025
pulisher
Mar 10, 2025

Sun Pharma to acquire US based onco-derma firm Checkpoint for $355 mn - Business Standard

Mar 10, 2025
pulisher
Mar 10, 2025

Sun Pharma to acquire 100% stake in Nasdaq-listed Checkpoint Therapeutics - Business Standard

Mar 10, 2025
pulisher
Mar 09, 2025

India's Sun Pharma to acquire Checkpoint Therapeutics for $355 million - Reuters

Mar 09, 2025
pulisher
Mar 09, 2025

India's Sun Pharma to acquire Checkpoint Therapeutics for $355 million -March 09, 2025 at 11:49 pm EDT - Marketscreener.com

Mar 09, 2025
pulisher
Mar 09, 2025

Sun Pharma to Acquire Checkpoint Therapeutics - Quantisnow

Mar 09, 2025
pulisher
Mar 09, 2025

India’s Sun Pharma to buy Checkpoint Therapeutics for $355 mln By Investing.com - Investing.com Australia

Mar 09, 2025
pulisher
Mar 09, 2025

India’s Sun Pharma to buy Checkpoint Therapeutics for $355 mln - Investing.com

Mar 09, 2025
pulisher
Mar 09, 2025

Sun Pharma to acquire Checkpoint Therapeutics for Rs 3,000 crore - Business Upturn

Mar 09, 2025
pulisher
Mar 05, 2025

Mustang Bio meets Nasdaq’s equity listing requirements By Investing.com - Investing.com South Africa

Mar 05, 2025
pulisher
Mar 05, 2025

Mustang Bio Regains Compliance with Nasdaq Capital Market Requirement - The Manila Times

Mar 05, 2025
pulisher
Feb 28, 2025

Fortress Biotech, Inc. (NASDAQ:FBIOP) Short Interest Down 78.3% in February - Defense World

Feb 28, 2025
pulisher
Feb 27, 2025

Mustang Bio Announces Sale of Fixed Assets and Exit of Facility - GlobeNewswire

Feb 27, 2025
pulisher
Feb 27, 2025

Trading (FBIOP) With Integrated Risk Controls - news.stocktradersdaily.com

Feb 27, 2025
pulisher
Feb 18, 2025

FDA extends review of Fortress Biotech's CUTX-101 drug - MSN

Feb 18, 2025
pulisher
Feb 17, 2025

Is Fortress Biotech Inc (NASDAQ: FBIO) Still Hot This Week? - Stocks Register

Feb 17, 2025
pulisher
Feb 16, 2025

(FBIOP) On The My Stocks Page - Stock Traders Daily

Feb 16, 2025
pulisher
Feb 14, 2025

Buying Buzz: Fortress Biotech Inc [FBIO] PRESIDENT, CEO & CHAIRMAN ROSENWALD LINDSAY A MD purchases 763,359 shares of the company – Knox Daily - Knox Daily

Feb 14, 2025

Fortress Biotech Inc (FBIO) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$70.69
price down icon 1.05%
$76.29
price down icon 2.18%
$31.13
price down icon 0.77%
$19.29
price down icon 5.07%
$91.06
price down icon 4.10%
biotechnology ONC
$272.17
price up icon 1.79%
자본화:     |  볼륨(24시간):